INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 05, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Mar 31, 2011 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 1,146 | $9.57 | 5,371 |
| Nov 21, 2014 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Open market or private sale of non-derivative or derivative security | 3,107 | $415.16 | 5,477 |
| Dec 18, 2012 |
SVP Res and Devel Sciences
|
SVP Res and Devel Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,479 |
| Dec 03, 2012 |
SVP Res and Devel Sciences
|
SVP Res and Devel Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,479 |
| Nov 21, 2012 |
SVP Res and Devel Sciences
|
SVP Res and Devel Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,479 |
| Aug 30, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,479 |
| Jun 20, 2012 |
SVP Res & Dev Sciences
|
SVP Res & Dev Sciences | Form 4 | Other acquisition or disposition | -- | -- | 5,479 |
| Dec 19, 2013 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,536 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.